Ignite Creation Date:
2025-12-24 @ 12:30 PM
Ignite Modification Date:
2026-04-15 @ 6:53 PM
Study NCT ID:
NCT02408861
Status:
TERMINATED
Last Update Posted:
2025-09-23
First Post:
2015-04-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Sponsor:
National Cancer Institute (NCI)
Organization:
Study Modules
Identification Module
Status Module
Sponsor Collaborators Module
Oversight Module
Description Module
Conditions Module
Design Module
Arms Interventions Module
Outcomes Module
Eligibility Module
Contacts Locations Module
References Module
Adverse Events Module
Baseline Characteristics Module
Participant Flow Module